Literature DB >> 28346792

Effects of IFN-γ on cell growth and the expression of ADAM33 gene in human embryonic lung Mrc-5 fibroblasts in vitro.

Wenjing Li1,2, Rongrong Liang1,2, Huarong Huang1,2, Baojing Wu1,2, Yingqiang Zhong2,3.   

Abstract

OBJECTIVE: To investigate the effects of interferon-γ (IFN-γ) on the proliferation and viability of human embryonic lung Mrc-5 fibroblasts in vitro and the expression of the A Disintegrin and Metalloprotease 33 (ADAM33) gene and to explore the mechanism of airway remodeling.
METHODS: Mrc-5 fibroblasts were sensitized with Dermatophagoides farinae 1 (Derf1) in vitro to mimic in vivo conditions observed in bronchial asthma. An inverted fluorescence microscope was used to observe changes in cell morphology before and after treatment. The viability of Mrc-5 cells was tested using the Cell Counting kit-8 (CCK8). Expression of the ADAM33 gene and protein in Mrc-5 cells was assessed using qPCR and Western blotting, respectively.
RESULTS: Different concentrations of Derf1 increased cell growth and the expression of the ADAM33 gene in Mrc-5 cells, and these changes were most obvious in the 10 µg/ml group. In contrast, IFN-γ decreased cell growth and the expression of the ADAM33 gene in both Mrc-5 cells and Derf1-induced Mrc-5 cells, and these changes were most obvious in the 10 ng/ml group. The negative effects of 10 ng/ml IFN-γ were the most significant at 32 hours.
CONCLUSIONS: Derf1-induced Mrc-5 cells successfully imitated the in vivo conditions observed in patients with asthma. IFN-γ inhibited the proliferation and viability of Mrc-5 cells, and Derf1-induced Mrc-5 cells were more sensitive to IFN-γ treatment. IFN-γ treatment significantly downregulated the expression of the ADAM33 gene in a concentration- and time-dependent manner. IFN-γ may participate in airway remodeling in asthma by regulating the expression of the ADAM33 gene.

Entities:  

Keywords:  ADAM33 gene; Derf1; IFN-γ; Mrc-5 cells; cell proliferation

Mesh:

Substances:

Year:  2017        PMID: 28346792     DOI: 10.1080/02770903.2017.1310226

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  4 in total

1.  Silencing a disintegrin and metalloproteinase‑33 attenuates the proliferation of vascular smooth muscle cells via PI3K/AKT pathway: Implications in the pathogenesis of airway vascular remodeling.

Authors:  Fang Yan; Yanyan Hao; Xinji Gong; Hu Sun; Jianbing Ding; Jing Wang
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

2.  M2 macrophages have unique transcriptomes but conditioned media does not promote profibrotic responses in lung fibroblasts or alveolar epithelial cells in vitro.

Authors:  Elissa M Hult; Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-07-07       Impact factor: 6.011

3.  ADAM33 Silencing Inhibits Vascular Smooth Muscle Cell Migration and Regulates Cytokine Secretion in Airway Vascular Remodeling via the PI3K/AKT/mTOR Pathway.

Authors:  Fang Yan; Xin Hu; Long He; Kegang Jiao; Yanyan Hao; Jing Wang
Journal:  Can Respir J       Date:  2022-08-31       Impact factor: 2.130

4.  Jinbei Oral Liquid ameliorates bleomycin-induced idiopathic pulmonary fibrosis in rats via reversion of Th1/Th2 shift.

Authors:  Xiao-Yan Xing; Wei-Jie Qiang; Jia-le Bao; Rui-Chuang Yang; Jun Hou; Kai Tao; Zhao-Qing Meng; Jing-Hua Zhang; Ai-Jun Zhang; Xiao-Bo Sun
Journal:  Chin Herb Med       Date:  2020-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.